|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/5377 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 4048278 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20807558.0 |
| Date of filing the European patent application | 2020-10-20 | |
| (97) | Date of publication of the European application | 2022-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation | 2023-12-11 |
| (86) | Number | PCT/US2020/056408 |
| Date | 2020-10-20 |
| (87) | Number | WO 2021/080935 |
| Date | 2021-04-29 |
| (30) | Number | Date | Country code |
| 201962924028 P | 2019-10-21 | US |
| (72) |
ANTON, Maria Soraya, Carrancio , US
BUCHHOLZ, Tonia J. , US
KASIBHATLA, Shailaja , US
LOPEZ-GIRONA, Antonia , US
NARLA, Rama, Krishna , US
POURDEHNAD, Michael , US
|
| (73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Hematologinio piktybinio naviko gydymo būdai, panaudojant 2-(2,6- dioksopiperidin-3-il)-4-((2-fluor-4-((3-morfolinoazetidin-1-il)metil)benzil) amino)izoindolin-1,3-dioną |
| METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZ YL)AMINO)ISOINDOLINE-1,3-DIONE |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 6 | 139.00 EUR |
| 2026-10-20 |